Home
Advanced Search
Help
Update History
Statistics
Downloads
The Barton Group

Predicted interactions involving protein WAS, IMD2: Wiskott-Aldrich syndrome protein (IPI00001545) that score above 12.5

Click on the protein name for more information about the protein.

The Score column is the predicted score of interaction between the two proteins

Click on the Evidence link to view a breakdown of the information about the predicted interaction.

Key
Module ScoreDatabases
Where interaction is observed in another database a link is provided:

Protein 1 (?)Protein 2 (?) Name of Protein 2 Module Scores (?) Scores (?) Evidence (?) Database (?)
WAS WASPIP N/A 5.98E4 Evidence
WAS VAV1 VAV1, VAV: Proto-oncogene vav 3.10E4 Evidence
WAS ACTG1 ACTB: Actin, cytoplasmic 1 2.80E4 Evidence
WAS ACTG1 ACTR2, ARP2: Actin-related protein 2 1.59E4 Evidence
WAS FGR FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR 1.20E4 Evidence O
WAS CD2AP CD2AP: CD2-associated protein 1.01E4 Evidence
WAS HCK N/A 9.29E3 Evidence O
WAS WASL WASL: Neural Wiskott-Aldrich syndrome protein 6.70E3 Evidence
WAS NCK1 NCK1, NCK: Cytoplasmic protein NCK1 5.62E3 Evidence O
WAS SH3KBP1 SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 4.68E3 Evidence
WAS CRKL CRKL: Crk-like protein 3.35E3 Evidence O
WAS CFL1 CFL1, CFL: Cofilin-1 1.12E3 Evidence
WAS GRAP GRAP: GRB2-related adapter protein 1.01E3 Evidence
WAS GRB2 GRB2, ASH: Growth factor receptor-bound protein 2 717.0 Evidence
WAS FRK FRK, PTK5, RAK: Tyrosine-protein kinase FRK 702.0 Evidence
WAS HCLS1 HCLS1, HS1: Hematopoietic lineage cell-specific protein 678.0 Evidence
WAS ACTR3 ACTR3, ARP3: Actin-related protein 3 373.0 Evidence
WAS CSK CSK: Tyrosine-protein kinase CSK 226.0 Evidence
WAS LYN LYN: Tyrosine-protein kinase Lyn 194.0 Evidence
WAS TYK2 TYK2: Non-receptor tyrosine-protein kinase TYK2 194.0 Evidence
WAS RAP1B RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor 194.0 Evidence
WAS ACTC ACTC1, ACTC: Actin, alpha cardiac muscle 1 191.0 Evidence O
WAS JAK2 JAK2: Tyrosine-protein kinase JAK2 174.0 Evidence
WAS SH3BP2 SH3BP2: Uncharacterized protein SH3BP2 165.0 Evidence
WAS DOCK2 DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 148.0 Evidence
WAS RPS6KA1 RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 148.0 Evidence
WAS CRK N/A 146.0 Evidence
WAS SYK SYK: Tyrosine-protein kinase SYK 105.0 Evidence
WAS MSN MSN: Moesin 98.10 Evidence
WAS STAT5A STAT5A, STAT5: Signal transducer and activator of transcription 5A 85.20 Evidence
WAS LCP2 LCP2: Lymphocyte cytosolic protein 2 77.90 Evidence O
WAS PIK3CG PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i 69.40 Evidence
WAS JAK1 69.40 Evidence
WAS RAF1 RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase 69.40 Evidence
WAS ACTA1 ACTA1, ACTA: Actin, alpha skeletal muscle 68.60 Evidence
WAS SCAP2 SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 67.20 Evidence
WAS ZAP70 ZAP70: Uncharacterized protein ZAP70 62.90 Evidence
WAS KHDRBS1 KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate 59.00 Evidence
WAS CSF1R CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor 56.20 Evidence
WAS BTK BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK 55.10 Evidence O
WAS MAP4K1 MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 49.60 Evidence
WAS ESX1 ESX1L, ESX1R: Extraembryonic, spermatogenesis, homeobox 1-like protein 44.90 Evidence
WAS TBK1 TBK1, NAK: Serine/threonine-protein kinase TBK1 44.40 Evidence
WAS PRKAA1 N/A 43.60 Evidence
WAS PRKD2 PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 42.00 Evidence
WAS ADRBK1 ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 42.00 Evidence
WAS LCP1 LCP1, PLS2: Plastin-2 37.80 Evidence
WAS MAP2K5 N/A 37.80 Evidence
WAS BLNK BLNK, BASH, SLP65: B-cell linker protein 36.60 Evidence
WAS ACTB ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 35.60 Evidence
WAS FNBP1 N/A 35.10 Evidence
WAS OSTF1 N/A 35.00 Evidence
WAS STK38L STK38L, KIAA0965, NDR2: Serine/threonine-protein kinase 38-like 33.90 Evidence
WAS RPS6KB1 N/A 33.90 Evidence
WAS RGS2 RGS2, G0S8: Regulator of G-protein signaling 2 32.90 Evidence
WAS PKN2 PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 32.80 Evidence
WAS DOK1 DOK1: Docking protein 1 32.30 Evidence
WAS MYH9 MYH9: Myosin-9 31.40 Evidence
WAS PRKCQ PRKCQ, PRKCT: Protein kinase C theta type 31.20 Evidence
WAS CBLB CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B 29.30 Evidence
WAS YWHAB YWHAB: 14-3-3 protein beta/alpha 28.80 Evidence
WAS LCK LCK: Proto-oncogene tyrosine-protein kinase LCK 27.90 Evidence
WAS RASA3 RASA3: Ras GTPase-activating protein 3 26.80 Evidence
WAS SOS1 SOS1: Son of sevenless homolog 1 25.10 Evidence
WAS CD44 N/A 23.00 Evidence
WAS SRC SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src 22.70 Evidence
WAS STAT5B STAT5B: Signal transducer and activator of transcription 5B 22.30 Evidence
WAS PTPN12 PTPN12: Tyrosine-protein phosphatase non-receptor type 12 21.20 Evidence O
WAS EEF2K EEF2K: Elongation factor 2 kinase 20.50 Evidence
WAS TXK TXK, PTK4: Tyrosine-protein kinase TXK 20.50 Evidence
WAS PIK3CB PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit 20.40 Evidence
WAS CSNK1E CSNK1E: Casein kinase I isoform epsilon 20.40 Evidence
WAS APS SH2B2, APS: SH2B adapter protein 2 20.40 Evidence
WAS LNK SH2B3, LNK: SH2B adapter protein 3 19.70 Evidence
WAS MINK1 MAP4K6, MINK1, MINK: Misshapen-like kinase 1 19.70 Evidence
WAS AMPH AMPH, AMPH1: Amphiphysin 19.70 Evidence
WAS ABI1 ABI1, SSH3BP1: Abl interactor 1 19.70 Evidence
WAS MAPK15 N/A 19.70 Evidence
WAS ABL2 ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 19.70 Evidence
WAS HLA-A HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor 18.80 Evidence
WAS PCBP1 PCBP1: Poly(rC)-binding protein 1 17.90 Evidence
WAS RASA1 RASA1, RASA: Ras GTPase-activating protein 1 17.60 Evidence
WAS CDC2L5 CDC2L5, CDC2L, CHED, KIAA1791: Cell division cycle 2-like protein kinase 5 17.60 Evidence
WAS ITK ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK 17.60 Evidence O
WAS NEDD9 NEDD9, CASL: Enhancer of filamentation 1 17.60 Evidence
WAS STAT3 17.60 Evidence
WAS CASP8 N/A 17.20 Evidence
WAS ABL1 ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 17.10 Evidence
WAS ELMO1 N/A 17.10 Evidence
WAS JUNB JUNB: Transcription factor jun-B 16.80 Evidence
WAS KIT KIT: Mast/stem cell growth factor receptor precursor 16.60 Evidence
WAS MICAL-L1 MICALL1, KIAA1668, MIRAB13: MICAL-like protein 1 16.20 Evidence
WAS CTTN CTTN, EMS1: Src substrate cortactin 16.00 Evidence
WAS CMTM6 CMTM6, CKLFSF6: CKLF-like MARVEL transmembrane domain-containing protein 6 15.60 Evidence
WAS PSKH1 PSKH1: Serine/threonine-protein kinase H1 15.50 Evidence
WAS HNRPK N/A 15.40 Evidence
WAS PTPN6 PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 15.00 Evidence
WAS FLT1 FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor 14.90 Evidence
WAS PDGFRA PDGFRA: Alpha-type platelet-derived growth factor receptor precursor 14.90 Evidence
WAS PDGFRB PDGFRB: Beta-type platelet-derived growth factor receptor precursor 14.90 Evidence
WAS CSF2RB CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor 14.70 Evidence
WAS CSNK1G2 CSNK1G2: Casein kinase I isoform gamma-2 14.70 Evidence
WAS ATR ATR, FRP1: Serine/threonine-protein kinase ATR 14.40 Evidence
WAS IRS2 IRS2: Insulin receptor substrate 2 14.10 Evidence
WAS GSK3A GSK3A: Glycogen synthase kinase-3 alpha 13.50 Evidence
WAS PHKG1 PHKG1, PHKG: Phosphorylase b kinase gamma catalytic chain, skeletal muscle isofo 13.40 Evidence
WAS LATS1 LATS1, WARTS: Serine/threonine-protein kinase LATS1 13.40 Evidence
WAS PTK2B PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta 13.40 Evidence
WAS CDC2 CDC2: Cell division control protein 2 homolog 13.40 Evidence
WAS FLT3 FLT3, STK1: FL cytokine receptor precursor 13.40 Evidence
WAS ALOX5 ALOX5, LOG5: Arachidonate 5-lipoxygenase 13.10 Evidence
WAS ADAM15 ADAM15, MDC15: ADAM 15 precursor 13.00 Evidence
WAS IL2RB IL2RB: Interleukin-2 receptor subunit beta precursor 12.60 Evidence
WAS GRAP2 GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 12.60 Evidence
WAS NCK2 NCK2: Cytoplasmic protein NCK2 12.60 Evidence